Juneau Biosciences

Juneau Biosciences

Research, 2749 E Parleys Way Ste 300, Salt Lake City, Utah, 84109, United States, 11-50 Employees

juneaubiosciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 80********

Who is JUNEAU BIOSCIENCES

Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. ...

Read More

map
  • 2749 E Parleys Way Ste 300, Salt Lake City, Utah, 84109, United States Headquarters: 2749 E Parleys Way Ste 300, Salt Lake City, Utah, 84109, United States
  • 2007 Date Founded: 2007
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Research

SIC SIC Code: 3845 | NAICS Code: 325413 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from JUNEAU BIOSCIENCES

Juneau Biosciences Org Chart and Mapping

Employees

Harley Newton

Director of Software and Informatics

Karen Miller

Medical Research Consultant

Jeff Ward

Regional Sales Executive

Kelli Louie

Laboratory Supervisor

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Juneau Biosciences

Answer: Juneau Biosciences's headquarters are located at 2749 E Parleys Way Ste 300, Salt Lake City, Utah, 84109, United States

Answer: Juneau Biosciences's phone number is 80********

Answer: Juneau Biosciences's official website is https://juneaubiosciences.com

Answer: Juneau Biosciences's revenue is $1 Million to $5 Million

Answer: Juneau Biosciences's SIC: 3845

Answer: Juneau Biosciences's NAICS: 325413

Answer: Juneau Biosciences has 11-50 employees

Answer: Juneau Biosciences is in Research

Answer: Juneau Biosciences contact info: Phone number: 80******** Website: https://juneaubiosciences.com

Answer: Juneau Biosciences is a privately held medical genetics company conducting groundbreaking research to develop innovative diagnostic products for diseases that predominantly affect women. Launched in early 2007, the Salt Lake City, Utah-based firm has focused so far on the development of novel molecular diagnostics and therapeutics for endometriosis, a condition estimated to affect approximately 10% of reproductive-age females. This research is the basis of all the tests and therapies that we will produce, patent, and disseminate to signal the revolution in womens health care. Research of other conditions is already underway. Over the next several years, Juneau will launch additional programs for preterm labor and other gynecological and obstetric disorders. Juneau expects to improve the lives of millions of women through our genetic research and innovative health care solutions. Juneau Biosciences knowledgeable team, state-of-the-art facilities, and innovative research techniques give us a unique advantage in developing diagnostics and treatments for women. We plan to form strategic alliances with health care partners that will complement our technologies and capabilities in order to commercialize these novel discoveries.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access